

Sponsors
ITOC12 thankfully acknowledges the support of the following companies and institutions
(listing in alphabetical order)

Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops and delivers new standards of care to enrich the quality of life around the world. With more than 120 years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular and other diseases with high unmet medical need. For more information, please visit www.daiichisankyo.com.
EUR 9.500,-

Gilead and Kite Oncology are working to transform how cancer is treated. We are innovating with next-generation therapies, combinations and technologies to deliver improved outcomes for people with cancer. We are purposefully building our oncology portfolio and pipeline to address the greatest gaps in care. From antibody-drug conjugate technologies and small molecules to cell therapy-based approaches, we are creating new possibilities for people with cancer. Read more: https://www.gileadsciences.de/
EUR 3.500,-

EUR 3.800,-

The purpose of the Wolfgang Wilmanns Foundation is the support of leukaemia and tumour research at the universities in Munich with the involvement of the TZM. This purpose is particularly fulfilled through awarding prizes to young researchers or research groups at the universities in Munich for outstanding performance in this area. The foundation is a non-profit organisation. Click to read more.
EUR 1.000,-
We herewith confirm that all sponsorship income is free of any attempt to influence the programme, individual sessions, subjects for discussions, content or choice of faculty members